ADU: Lose Lose, either way

That about sums it up.

 

If only...

 

It will be very slim pickings unless they want to swap out some underperforming MS reps. Biogen’s pipeline isn’t looking very healthy at the moment.

 

That's right... don't see many options if this doesn't get approved.

 

Three AALs have already left. Many more in groups 3&4 waiting for the 1 year anniversary to resign.

Wonder how many will wait out the June date or cut bait since the company misrepresented the position.

 

Gotta do your homework people. Both pivotals failed. Across all of pharma in recent decades there has NEVER been a drug approved based of a single post-hoc analysis in one trial.

Accepting a high risk position is not on the sketchy recruiter or company, but on the applicant. Buyer beware.

 

you very DRAMZ. This was a start-up within a an established brand. There was zero misrepresentation.

 

Although there likely will not be an approval, you are wrong on your stated fact as some oncology drugs have.
You act as if everyone is sad though. Many are done and realize that the job would have been the worst job of their entire careers.

 

Oncology is completely different from all other areas. Neuroscience division of FDA is super conservative for non orphan indications. That said, it’s probably unrealistic to expect sales force to have regulatory insight. The hiring manager says “drug is likely to be approved” and they sign I guess.

 

Thats not accurate in this case. How come FDA's own Neurology director Billy Dunn has been agressively pushing Aducanumab as a miracle drug since day one????? Clearly, he is incredibly biased, but the FDA wants to approve. That said, I also don't think they will approve due to many factors.

 

Exactly! I'd rather it not see it get approved if there is a terrible label and conditions. Just end this nightmare!

 

At this point, after seeing how badly things are going and overall perceptions and what this crap show would look like, most just don't want it to happen. It will be that miserable.

 

Aducanumab won't get approved. There are too many problems and too much controversy. Either way, if it were to get approved, that would go very badly. So yes, I agree that it really doesn't matter the decision. It is bad. Time to let this dud to rest and focus on other mechanisms of action that will truly be better.

 

Late Breaking News-FDA requested more studies today prior to approval. Lay-off Calls next week. 2 weeks severance per year employed. Enjoy the weekend.

 

Is this true, wave 2 here wondering what’s going on over there.

 

Bye bye family summer vacations!

 

Hell you must be a dope sitting on your azz for past 8 months. Smart reps have enjoyed the free ride these past 8 months and have been vacationing the entire time.

 

I heard this too - starting to look for new job Monday Morning

 

NOT GETTING APPROVED

 

The loser boy is hard at work posting mindless posts from down under in his mom’s basement.